Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 360-365 , March 2010

Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses

  • Helena W. Rodbard

      Affiliations

    • Endocrine and Metabolic Associates, Rockville, MD, USA
    • ,
  • Andrew J. Green

      Affiliations

    • Midwestern Endocrinology, Overland Park, KS, USA
    • ,
  • Kathleen M. Fox

      Affiliations

    • Strategic Healthcare Solutions, LLC, Monkton, MD, USA
    • Corresponding Author InformationCorresponding author at: P.O. Box 543, Monkton, MD 21111, USA. Tel.: +1 443 690 2198; fax: +1 410 357 8018.
    • ,
  • Susan Grandy

      Affiliations

    • AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
    • ,
  • for the SHIELD Study Group

Received 31 July 2009 ,Revised 24 November 2009 ,Accepted 30 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This research was supported by AstraZeneca Pharmaceuticals LP.

PII: S0168-8227(09)00492-6

doi: 10.1016/j.diabres.2009.11.021

Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 360-365 , March 2010

Article Tools

* Image Usage & Resolution